Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 3, 2021, Cara Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders ("Annual Meeting"). At the Annual Meeting, the Company's stockholders voted on the three proposals set forth below. A more detailed description of each proposal is set forth in the Company's Proxy Statement filed with the Securities and Exchange Commission on April 23, 2021.

Proposal 1 - Election of Directors

Mr. Harrison M. Bains, Jr. and Dr. Susan Shiff, Ph.D. were each elected to serve as a director of the Company's Board of Directors until the 2024 Annual Meeting of Stockholders and until his or her successor is duly elected or until his or her earlier resignation or removal, by the following votes:

Nominee Votes For Votes Withheld Broker Non-Votes Harrison M. Bains, Jr 28,448,858 836,904 11,995,880 Susan Shiff, Ph.D. 27,902,976 1,382,786 11,995,880

Proposal 2 - Approval, on a Non-Binding Advisory Basis, of the Compensation of the Company's Named Executive Officers

The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, by the following votes:





Votes For    Votes Against   Abstentions   Broker Non-Votes
28,190,965      979,010        115,787        11,995,880



Proposal 3 - Ratification of the Selection of Independent Registered Public Accounting Firm

The stockholders ratified the selection by the Audit Committee of the Board of Directors of the Company of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021, by the following votes:





Votes For    Votes Against   Votes Abstain   Broker Non-Votes
39,581,075     1,661,532        39,035              -

© Edgar Online, source Glimpses